BCL9 and neoplasm: Interestingly, subcutaneous grafting of the same organoids in immuno-compromised mice resulted in tumor regression in allografts lacking Bcl9/9l while the wild-type organoids grew exponentially, consistent with their Apc −/− and mutated Kras background.